Dr. Morales discusses how COVID-19 affects the clinical trial supply chain, IP Strategy, and transitioning from pre-clinical to clinical.<a rel="payment" href="https://www.buzzsprout.com/1208600/support">Support the show</a>Check me out on LinkedIn https://www.linkedin.com/in/ammonr/

Dr. Morales discusses how COVID-19 affects the clinical trial supply chain, IP Strategy, and transitioning from pre-clinical to clinical.Support the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/

Dr. Morales discusses how COVID-19 affects the clinical trial supply chain, IP Strategy, and transitioning from pre-clinical to clinical.<a href="https://www.buzzsprout.com/1208600/support" rel="noopener noreferrer">Support the show</a>Check me out on LinkedIn https://www.linkedin.com/in/ammonr/

#2 Guillermo Morales - CEO Innoventyx

Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each function plays an important role in the drug approval process. We also discuss the people that make up these departments. Get ready to hear about cutting edge development and the people who make it happen!

Share #2 Guillermo Morales - CEO Innoventyx

Sign up to save your podcasts

#2 Guillermo Morales - CEO Innoventyx

#2 Guillermo Morales - CEO Innoventyx